BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12728402)

  • 1. Overview of non-Hodgkin's lymphoma: biology, staging, and treatment.
    Fisher RI
    Semin Oncol; 2003 Apr; 30(2 Suppl 4):3-9. PubMed ID: 12728402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
    Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.
    Long J; Versea L
    Semin Oncol Nurs; 2006 May; 22(2):97-106. PubMed ID: 16720232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
    Naparstek E
    Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin lymphoma: diagnosis and treatment.
    Ansell SM; Armitage J
    Mayo Clin Proc; 2005 Aug; 80(8):1087-97. PubMed ID: 16092591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments for indolent lymphoma.
    Cheson BD; Gregory SA; Marcus R
    Clin Adv Hematol Oncol; 2007 May; 5(5 Suppl 8):1-9; quiz 11-2. PubMed ID: 17637594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
    Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
    Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised European-American Lymphoma Classification.
    Pileri SA; Leoncini L; Falini B
    Curr Opin Oncol; 1995 Sep; 7(5):401-7. PubMed ID: 8541383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A; Forman SJ
    Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The World Health Organization classification of lymphomas.
    Jakić-Razumović J; Aurer I
    Croat Med J; 2002 Oct; 43(5):527-34. PubMed ID: 12402390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in the treatment of non-Hodgkin's lymphomas].
    Varga F; Demeter J
    Magy Onkol; 2001; 45(1):45-50. PubMed ID: 12050728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma.
    Winter JN
    Curr Opin Hematol; 2007 Jul; 14(4):360-8. PubMed ID: 17534162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-Hodgkin lymphomas: classification, staging and therapy].
    Obrecht JP
    Schweiz Med Wochenschr; 1979 Mar; 109(11):403-9. PubMed ID: 424710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
    Aydin S; Dührsen U; Nückel H
    Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
    Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
    Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of non-Hodgkin's lymphoma.
    Coffey J; Hodgson DC; Gospodarowicz MK
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S28-36. PubMed ID: 12692688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical approach to the pathology of lymphoid neoplasms: a revised European-American classification from the International Lymphoma Study Group.
    Harris NL
    Important Adv Oncol; 1995; ():111-40. PubMed ID: 7672801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.